---
title: 'Exploring the efficacy of dialectical behaviour therapy and methylphenidate
  on emotional comorbid symptoms in adults with attention Deficit/Hyperactivity disorder:
  Results of the COMPAS multicentre randomised controlled trial'
date: '2023-11-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37992514/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231123171003&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: This study evaluated the efficacy of dialectical behaviour group therapy
  (GPT) vs. individual clinical management (CM) and methylphenidate (MPH) vs. placebo
  (PLB) on emotional symptoms in adults with ADHD. This longitudinal multicentre RCT
  compared four groups (GPT+MPH, GPT+PLB, CM+MPH, and CM+PLB) over five assessment
  periods, from baseline to week 130. Emotional symptomatology was assessed using
  SCL-90-R subscales. Of the 433 randomised participants, 371 remained for final analysis.
  At ...
disable_comments: true
---
This study evaluated the efficacy of dialectical behaviour group therapy (GPT) vs. individual clinical management (CM) and methylphenidate (MPH) vs. placebo (PLB) on emotional symptoms in adults with ADHD. This longitudinal multicentre RCT compared four groups (GPT+MPH, GPT+PLB, CM+MPH, and CM+PLB) over five assessment periods, from baseline to week 130. Emotional symptomatology was assessed using SCL-90-R subscales. Of the 433 randomised participants, 371 remained for final analysis. At ...